OIRA Conclusion of EO 12866 Regulatory Review
RIN: 0938-AV24 View EO 12866 Meetings | Received Date: 02/22/2024 |
Title: Contract Year 2025 Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, and Medicare Cost Plan Programs, and PACE (CMS-4205) | |
Agency/Subagency: HHS / CMS | Stage: Final Rule |
Concluded Action: Consistent with Change | Concluded Date: 03/29/2024 |
Section 3(f)(1) Significant *: Yes | |
Legal Deadline: Statutory | Economically Significant **: No |
Publication Date: | Unfunded Mandates: No |
Major: Yes | Related To Homeland Security: No |
Regulatory Flexibility Analysis Required: Undetermined | Small Entities Affected: |
Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
Pandemic Response: No | |
|